The most widely used staging system for prostate cancer is the AJCC TNM system (tumour, node, metastasis), which is based on PSA level, grade group (Gleason score), and extent of the cancer (T, N, and M categories). This evidence concerns the gene KLK3 and prostate carcinoma.